RNS Number:4964M
BioProgress PLC
18 June 2003


                        BioProgress PLC ('BioProgress')

                           Form 10-Q Filing With SEC

BioProgress Technology International, Inc., a wholly owned subsidiary of
BioProgress PLC, files Quarterly Report On Form 10-Q for the Quarter Ended March
31, 2003

A copy of the BioProgress Technology International, Inc. Quarterly Report on
Form 10-Q for the quarter ended March 31, 2003 has been submitted to the
Securities Exchange Commission ("SEC"), and will be publicly available for
inspection at the SEC website (http://www.sec.gov).


Contact Details
UK
BioProgress PLC Contact
Graham Hind, Managing Director
Hostmoor Avenue
March Cambs, PE15 0AX
United Kingdom
Tel: +44 (0) 1354 655 674
Fax: +44 (0) 1354 657 800
Email: bjm@bioprogress.com
Email: grahamhind@bioprogress.com

USA
Company Contact and Investor Relations
Larry C. Shattles, Executive Vice President,
BioProgress Technology International, Inc.,
P.O. Box 500127
Atlanta, GA 31150
Tel: +1 (770) 649 1133
Fax: +1 (770) 594 8613
Email: lcs@bioprogress.com
Email: cbb@bioprogress.com

Rest of the World
Media Contact and Investor Relations for the rest of the World:
Henry Harrison-Topham
Bankside Consultants Limited
St. Mary Abchurch House
123 Cannon Street
London EC4N 5AU
Tel: +44 (0) 207 444 4140
Fax: +44 (0) 207 444 4184
Email: henry.ht@bankside.com

Website:
www.BioProgress.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DOCFPMFTMMTBBIJ